Cancellation of state registration. Blocordil®

May 2, 2017
Active substances:
Trade names:
ICD-10:
IX.I10-I15.I10    Essential [primary] hypertension
IX.I10-I15.I15.0    Renovascular hypertension
IX.I30-I52.I50.0    Congestive heart failure
XIV.N00-N08.N08.3 *    Glomerular lesions in diabetes mellitus (E10-E14 + with the common fourth sign .2)
Blokordil, captopril, arterial hypertension, renovascular hypertension, diabetic nephropathy, treatment of chronic heart failure

Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Lawfrom 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclusion from the state register of medicinal products for medical use of the medicinal product (registration certificate P N012811 / 01 dated 08.12.2010 issued KRKA, dd. , Novo mesto, Slovenia):

Blocordil® (trade name of the medicinal product)

Captopril (international non-proprietary, or grouping, or chemical name medicinal product)

tablets, 12.5 mg, 25 mg, 50 mg (dosage form, dosage)

KRKA, dd, Novo mesto, Slovenia Smarjcska cesta 6, 8501 Novo mesto, Slovenia (name and address of the location of the manufacturer of the medicinal product)

on the basis of the submission by the authorized representative of the JSC "Krka, dd, Novo mesto", Russia, a statement on the abolition of the state registration of the medicinal product.